title: Asymmetric dimethylarginine may contribute to vascular risk factors in patients receiving antiepileptic drug treatment.
authors.forename: Oğuzhan
authors.initials: O
authors.lastname: Oz
authors.forename: Hakan
authors.initials: H
authors.lastname: Akgün
authors.forename: Mehmet
authors.initials: M
authors.lastname: Yücel
authors.forename: Zeki
authors.initials: Z
authors.lastname: Gökçil
authors.forename: Zeki
authors.initials: Z
authors.lastname: Odabaşi
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects*; D050197:Atherosclerosis / Q000139:chemically induced*; D002220:Carbamazepine / Q000009:adverse effects*; D017536:Carotid Artery, Common / Q000473:pathology*; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010672:Phenytoin / Q000009:adverse effects*; D014635:Valproic Acid / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin